Research Compound - Metabolic
Triple Agonist / Amylin Analogue Research Combination
A combination of Retatrutide, a GLP-1/GIP/glucagon triple agonist, and Cagrilintide, a long-acting amylin receptor agonist, supplied together as a research tool for studies investigating combined incretin and amylin receptor signaling.
For research and scientific purposes only. Not intended for human therapeutic use, diagnosis, treatment or consumption of any kind.
A combination of Retatrutide, a GLP-1/GIP/glucagon triple agonist, and Cagrilintide, a long-acting amylin receptor agonist, supplied together as a research tool for studies investigating combined incretin and amylin receptor signaling.
Pairing a triple incretin-receptor agonist with an amylin-receptor agonist allows in-vitro study of cross-pathway signaling interactions between the incretin and amylin systems.
This material is intended solely for qualified laboratory research and analytical applications. It is not intended for human or veterinary use, clinical administration, diagnosis, treatment or prevention of any disease or condition.
Each compound is supplied separately and should be reconstituted individually per its own concentration reference.
This vial contains 5 mg of peptide.
We ship across the European Union. Orders are processed within 1–2 business days and typically arrive within 3–5 business days to most EU destinations. All peptides are dispatched in secure packaging, with a tracking number sent once your order leaves our facility. Free shipping on orders over €199.
A combination of Retatrutide, a GLP-1/GIP/glucagon triple agonist, and Cagrilintide, a long-acting amylin receptor agonist, supplied together as a research tool for studies investigating combined incretin and amylin receptor signaling. It is supplied strictly for laboratory research and is not approved for human therapeutic use.
We ship across the European Union. Orders are processed within 1-2 business days and typically arrive within 3-5 business days to most EU destinations, dispatched in secure packaging.
Retatrutide + Cagrilintide is supplied as 5mg + 5mg, Lyophilised Powder. Each compound is supplied separately and should be reconstituted individually per its own concentration reference.
Yes. All PeptiLux compounds are manufactured under GMP conditions in ISO 9001 and 13485 certified facilities, and independently verified by HPLC to greater than 99% purity on a batch-by-batch basis. Certificates of Analysis are available on request.